tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2020 Jul 30;26(11).
doi: 10.3201/eid2611.203029. Online ahead of print.
Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
Amy K Feehan, Daniel Fort, Julia Garcia-Diaz, Eboni Price-Haywood, Cruz Velasco, Eric Sapp, Dawn Pevey, Leonardo Seoane
Abstract
Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
Keywords: COVID-19; Louisiana; New Orleans; SARS-CoV-2; United States; convalescence; coronavirus disease; cross-sectional studies; healthcare disparities; prevalence; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
. 2020 Jul 30;26(11).
doi: 10.3201/eid2611.203029. Online ahead of print.
Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020
Amy K Feehan, Daniel Fort, Julia Garcia-Diaz, Eboni Price-Haywood, Cruz Velasco, Eric Sapp, Dawn Pevey, Leonardo Seoane
- PMID: 32731911
- DOI: 10.3201/eid2611.203029
Abstract
Using a novel recruitment method and paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a racially diverse municipality in Louisiana, USA. Infections were highly variable by ZIP code and differed by race/ethnicity. Overall census-weighted seroprevalence was 6.9%, and the calculated infection fatality ratio was 1.63%.
Keywords: COVID-19; Louisiana; New Orleans; SARS-CoV-2; United States; convalescence; coronavirus disease; cross-sectional studies; healthcare disparities; prevalence; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.